Buy MYNZ by Apr 15, 2026.

If you trade catalysts, map the dates and ignore the noise. For MYNZ, I set three near term anchors. First, AACR 2026 in San Diego, where the pancreatic verification read uses a compact blood mRNA panel with an AI model to detect PDAC and sort IPMN. Prior feasibility printed 100 percent sensitivity and 95 percent specificity in 30 subjects; the question is whether the trimmed panel holds up. Second, eAArly DETECT 2 feasibility for CRC is guided to wrap in …